Sodium Acetate Injection
Product Images NDC 0641-6261

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sodium Acetate (NDC 0641-6261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sodium Acetate 20 mL Vial Label (Sodium Acetate Injection Usp Sdv 1)

Sodium Acetate Injection, USP 40 mEq per 20 mL (2 mEq/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. The label states the product contains sodium acetate, anhydrous 164 mg/mL, is sterile and nonpyrogenic. It is a 20 mL single-dose vial requiring dilution before intravenous use. Storage instructions and manufacturing information are also visible.*

FDA Label Image

Sodium Acetate 20 mL Carton (Sodium Acetate Injection Usp Sdv 2)

Box packaging label for Sodium Acetate Injection, USP, 40 mEq per 20 mL (2 mEq/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. The label specifies it is a single-dose vial of 20 mL with a caution stating that the product must be diluted before use. It includes storage instructions, dosage note, and aseptic technique guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.